GB0002527D0 - Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction - Google Patents
Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infactionInfo
- Publication number
- GB0002527D0 GB0002527D0 GB0002527A GB0002527A GB0002527D0 GB 0002527 D0 GB0002527 D0 GB 0002527D0 GB 0002527 A GB0002527 A GB 0002527A GB 0002527 A GB0002527 A GB 0002527A GB 0002527 D0 GB0002527 D0 GB 0002527D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- growth factor
- plgf
- vegf
- ischemic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102100035194 Placenta growth factor Human genes 0.000 title 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 title 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title 2
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 title 1
- 101150062285 PGF gene Proteins 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 230000002107 myocardial effect Effects 0.000 title 1
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0002527A GB0002527D0 (en) | 2000-02-04 | 2000-02-04 | Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction |
AU46435/01A AU4643501A (en) | 2000-02-04 | 2001-02-02 | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke |
PCT/EP2001/001659 WO2001057181A2 (en) | 2000-02-04 | 2001-02-02 | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke |
PT01902406T PT1253935E (en) | 2000-02-04 | 2001-02-05 | CABINET SCREW ESPECIALLY ADAPTED TO A PRESSURE AND FITTING POINT |
AT01902406T ATE324905T1 (en) | 2000-02-04 | 2001-02-05 | USE OF PLGF TO PREVENT OR TREAT SCHAEMIA OR STROKE |
JP2001556492A JP4969753B2 (en) | 2000-02-04 | 2001-02-05 | Pharmaceutical composition for reducing infarct size during treatment of ischemic disease |
DE60119285T DE60119285T2 (en) | 2000-02-04 | 2001-02-05 | USE OF PLGF TO PREVENT OR TREAT ISCHAEMIE OR HITCH |
AU2001230243A AU2001230243A1 (en) | 2000-02-04 | 2001-02-05 | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke |
EP01902406A EP1253935B1 (en) | 2000-02-04 | 2001-02-05 | Use of placenta growth factor for preventing or treating ischemic diseases or stroke |
DK01902406T DK1253935T3 (en) | 2000-02-04 | 2001-02-05 | Use of placental growth factor to prevent or treat ischemic disease or stroke |
ES01902406T ES2263582T3 (en) | 2000-02-04 | 2001-02-05 | USE OF THE GROWTH FACTOR TO PREVENT OR TREAT ISCHEMICAL CARDIOPATIAS OR CARDIOVASCULAR ACCIDENTS. |
PCT/EP2001/001208 WO2001056593A2 (en) | 2000-02-04 | 2001-02-05 | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke |
US10/182,359 US6930089B2 (en) | 2000-02-04 | 2001-02-05 | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke |
US11/471,823 US7727971B2 (en) | 2000-02-04 | 2006-06-21 | Use of placental growth factor for treating ischemic muscle disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0002527A GB0002527D0 (en) | 2000-02-04 | 2000-02-04 | Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0002527D0 true GB0002527D0 (en) | 2000-03-29 |
Family
ID=9884925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0002527A Ceased GB0002527D0 (en) | 2000-02-04 | 2000-02-04 | Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0002527D0 (en) |
-
2000
- 2000-02-04 GB GB0002527A patent/GB0002527D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2583399A (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
HK1041833A1 (en) | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | |
IL158546A0 (en) | Prevention of myocardial infarction induced ventricular expansion and remodeling | |
AU3947902A (en) | Therapeutic agents and methods of use thereof for the modulation of angiogenesis | |
AU2001275339A1 (en) | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury | |
EP1359972A4 (en) | Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (vegf) using the same | |
EE200300165A (en) | Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction | |
HUP0301252A3 (en) | Endoparasiticidal agents based on starch and process for their preparation | |
HUP0300917A3 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them | |
HUP0200827A2 (en) | Vascular endothelial cell growth factor variants and uses thereof | |
AU2001270484A1 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
HUP0203957A3 (en) | Angiogenesis and vascular permeability modulators and inhibitors | |
EP1204672A4 (en) | High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors | |
MXPA03004303A (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain. | |
EP1194150A4 (en) | Use of nitroxides in wound healing and in the prevention of photodamage | |
AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
DE60021360D1 (en) | VEGF ANGIOGENIC GROWTH FACTORS FOR THE TREATMENT OF PERIPHERAL NEUROPATHY | |
GB0002527D0 (en) | Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction | |
EP1200133A4 (en) | Manipulation of tissue or organ type using the notch pathway | |
IL151992A0 (en) | Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists | |
HUP0302241A3 (en) | Use of ccr5 antagonist and dp-178 polypeptide for treating viral infections | |
AU2001230243A1 (en) | Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke | |
FI990735A0 (en) | Method of evaporating the solution and evaporator used in the method | |
DE50006845D1 (en) | LOCKER ARRANGEMENT FOR THE STORAGE AND DELIVERY OF ITEMS | |
MXPA02012942A (en) | New bispidine compounds and their use in the treatment of cardiac arrhythmias. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |